To explore the effects Shufeng Jiedu Capsules on inflammatory factors and clinical efficacy in patients with acute attack of chronic bronchitis of wind-heat attacking lung type.Methods:A total of 112 patients with acute attack of chronic bronchitis of wind-heat attacking lung type admitted to 904th Hospital of the Joint Service Support Force of the Chinese People's Liberation Army Hospital from January 2018 to April 2020 were selected as the research objects and were divided into an observation group and a control group,with 56 cases in each group.The observation group was treated with Shufeng Jiedu Capsules combined with piperacillin sodium tazobactam sodium for injection,ambroxol hydrochloride,budesonide suspension and acetylcysteine solution for inhalation,while the control group was treated with piperacillin sodium tazobactam sodium for injection,ambroxol hydrochloride,budesonide suspension and acetylcysteine solution for inhalation.The levels inflammatory factors,peripheral blood WBC level,time of clinical symptoms disappearing and efficacy of the 2 groups were compared.Results:After treatment,TNF-α,CRP levels of the observation group and control group were lower than those before treatment (P<0.05),and the observation group was lower than the control group (P<0.05); after treatment,WBC,N % level of the observation group and control group was lower than before treatment (P<0.05); after treatment,the disappearance time of rales and the average healing time in the control group were longer than those in the observation group (P<0.05); the total effective rate of the observation group was 91.07%,which was higher than the control group of 75.24% (P<0.05).Conclusion:Shufeng Jiedu Capsules combined with conventional Western medicine can effectively inhibit the inflammatory response of patients with acute attack of chronic bronchitis with wind-heat attacking lung,playing a significant anti-infection role,improving clinical symptoms and promoting the recovery of the disease.